UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations

Scientific reports, 2017-08, Vol.7 (1), p.7066-7066, Article 7066

2017

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions

Journal of experimental & clinical cancer research, 2021-10, Vol.40 (1), p.333-14, Article 333

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

International journal of cancer, 2019-09, Vol.145 (5), p.1179-1188

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting the indoleamine 2,3-dioxygenase pathway in cancer

Journal for Immunotherapy of Cancer, 2015-12, Vol.3 (1), p.51-51, Article 51

2015

Link zum Volltext

Verfügbarkeit prüfen

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence

Cancers, 2020-11, Vol.12 (12), p.3566

2020

Link zum Volltext

Verfügbarkeit prüfen

185 Ex vivo efficacy of adoptive T cell therapy using autologous CD8+ T cells isolated by PD-1 positivity from peripheral blood mononuclear cells in solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A197-A197

2021

Link zum Volltext

Verfügbarkeit prüfen

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.168-168, Article 168

2019

Link zum Volltext

Verfügbarkeit prüfen

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

International journal of molecular sciences, 2023-12, Vol.24 (23), p.17086

2023

Link zum Volltext

Verfügbarkeit prüfen

Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1223

2021

Link zum Volltext

Verfügbarkeit prüfen

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance

The Journal of clinical investigation, 2014-07, Vol.124 (7), p.3003-3015

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-325, Article 325

2023

Link zum Volltext

Verfügbarkeit prüfen

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer

BMC cancer, 2016-03, Vol.16 (224), p.224-224, Article 224

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer

Cancers, 2023-10, Vol.15 (19), p.4887

2023

Link zum Volltext

Verfügbarkeit prüfen

Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase

Cancers, 2022-01, Vol.14 (1), p.210

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited‐disease small‐cell lung cancer

Cancer, 2007-05, Vol.109 (9), p.1845-1950

2007

Link zum Volltext

Verfügbarkeit prüfen

Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics

Genes, 2021-01, Vol.12 (2), p.159

2021

Link zum Volltext

Verfügbarkeit prüfen

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution

PloS one, 2016-04, Vol.11 (4), p.e0154133-e0154133

2016

Link zum Volltext

Verfügbarkeit prüfen

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6234-6243

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Therapeutic advances in medical oncology, 2021-12, Vol.13, p.17588359211061989-17588359211061989

2021

Link zum Volltext

Verfügbarkeit prüfen

Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001513

2020

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

Molecular cancer therapeutics, 2015-10, Vol.14 (10), p.2238-2248

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

Journal for immunotherapy of cancer, 2019-08, Vol.7 (1), p.211-211, Article 211

2019

Link zum Volltext

Verfügbarkeit prüfen

Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute

Annals of surgical oncology, 2007-10, Vol.14 (10), p.2730-2737

2007

Link zum Volltext

Verfügbarkeit prüfen

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators

Journal of cancer research and clinical oncology, 2010-03, Vol.136 (3), p.387-394

2010

Link zum Volltext

Verfügbarkeit prüfen

Congestive heart failure and a swollen breast

The Lancet (British edition), 2004-01, Vol.363 (9404), p.210-210

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(182)
Tagungsberichte
(1)

Sprache

Englisch
(161)
Koreanisch
(22)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

Targeting the indoleamine 2,3-dioxygenase pathway in cancer

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence

185 Ex vivo efficacy of adoptive T cell therapy using autologous CD8+ T cells isolated by PD-1 positivity from peripheral blood mononuclear cells in solid tumors

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer

Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited‐disease small‐cell lung cancer

Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators

Congestive heart failure and a swollen breast

Suchergebnisse filtern